SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
____________________________________
Date of report (Date of earliest event reported): December
31, 1997
CRYOMEDICAL SCIENCES, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware 0-18170
94-3076866
(State or Other Juris- (Commission File
No.) (IRS Employer
diction of Incorporation)
Identification No.)
1300 Piccard Drive, Suit 102, Rockville, MD
20850
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code:
(301) 417-7070
N/A
(Former Name or Former Address, if Changed Since
Last Report.)
ITEM 4. Changes in Registrant's Certifying
Accountant.
On December 31, 1997, Aronson, Fetridge &
Weigle was engaged as the principal accountant to audit
the financial statements of Cryomedical Sciences, Inc.
ITEM 7. Financial Statements, Pro Forma Financial
Information and Exhibits
(c) Exhibits
None
<PAGE>
Signatures:
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this
report to be signed on its behalf by the undersigned
hereunto duly authorized.
CRYOMEDICAL SCIENCES, INC.
By: /s/ Richard Reinhart
Richard Reinhart
President and Chief Executive Officer
Date: January 6, 1998
